Safety assessments
gastrointestinal reactions, nausea, chest tightness, suffocation, fever, vomiting, palpitation, skin rash
ADVERSE EVENTS, ADVERSE EVENT, SUFFOCATION
Adverse events were evaluated and recorded every three days. All adverse events correlated with EGCG were recorded according to CTCAE, 5.0. These include but are not limited to drug-induced skin rash, nausea and vomiting and other gastrointestinal reactions, fever, palpitation, chest tightness, suffocation and other symptoms. At the same time, we should also distinguish whether the above symptoms are related to EGCG or radiotherapy and chemotherapy.